🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with do the heart benefits go away if i stop taking it??

Has anyone dealt with do the heart benefits go away if i stop taking it??

CanadaChris Sat, Jul 12, 2025 at 4:16 AM 28 replies 1,496 viewsPage 1 of 6
This thread is more than 11 months old. Information may be outdated. Consider searching for more recent discussions.
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Jul 12, 2025 at 4:16 AM#1

My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Relative versus absolute is the distinction that gets lost: a 20% relative reduction on a high baseline risk is a large absolute benefit, and the same relative figure on a low baseline risk is a small one.

The question I want answered is how much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical.

If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

43 21Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 40 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jul 12, 2025 at 6:18 AM#2
CanadaChris said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

SUSTAIN-6 was the first CVOT to show cardiovascular benefit with semaglutide, relevant to cardiovascular risk. In 3,297 T2DM patients with high CV risk: MACE HR 0.74 (95% CI 0.58-0.95, p=0.02)[1].

Notable: the retinopathy signal in SUSTAIN-6 (HR 1.76) was subsequently attributed to rapid A1C reduction in patients with pre-existing retinopathy — not a direct drug effect. This has been confirmed in longer-term follow-up studies.

References:
[1] Marso SP, et al. N Engl J Med. 2016;375(19):1834-1844.
44 22traveltech_sara, AttorneyGrant, DebRD_ATL and 41 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Jul 12, 2025 at 8:20 AM#3
LipidDoc_ATL said:
SUSTAIN-6 was the first CVOT to show cardiovascular benefit with semaglutide, relevant to cardiovascular risk.

I'm 67 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

17 months later: down 54 lbs, off metoprolol, A1C from 8.8% to 5.5%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

45 23Dr.NateNeph, PharmD_Rodriguez, julia.endo and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Jul 12, 2025 at 10:22 AM#4
CanadaChris said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

Last edited: Jul 12, 2025 at 3:22 PM
46 24KetoKyle, CanadaChris, ZaraB_AL and 43 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Jul 12, 2025 at 10:26 PM#5

Clinical perspective, offered as context rather than as advice.

Senior perspective on cardiovascular risk: I'm 62 years old and started this journey skeptically. My internist recommended it after years of failed interventions.

12 months later: down 45 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

47 0sarah_nash92, FitDadDave, RunnerRach and 44 others
Reply Quote Save Share Report
1236

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register